| Description |
1 online resource (758 pages) |
| Series |
Chapman & Hall/CRC Biostatistics Series, 27 |
|
Chapman & Hall/CRC Biostatistics Series, 27
|
| Contents |
Front cover; Contents; Preface; Authors; Part I: Preliminaries; Chapter 1. Introduction; Chapter 2. Design of Bioavailability Studies; Chapter 3. Statistical Inferences for Effects from a Standard 2 x 2 Crossover Design; Part II: Average Bioequivalence; Chapter 4. Statistical Methods for Average Bioequivalence; Chapter 5. Power and Sample Size Determination; Chapter 6. Transformation and Analysis of Individual Subject Ratios; Chapter 7. Assessment of Inter- and Intra-Subject Variabilities; Chapter 8. Assumptions of Outlier Detection for Average Bioequivalence |
| Summary |
Taking into account the regulatory and scientific developments that have occurred, this third edition provides a complete presentation of the progress of activities and results in bioavailability and bioequivalence on regulatory requirements, scientific and practical issues, and statistical methodology |
| Notes |
Print version record |
| Subject |
Bioavailability.
|
|
Statistics as Topic
|
|
Therapeutic Equivalency
|
|
Biological Availability
|
|
Bioavailability
|
| Form |
Electronic book
|
| Author |
Liu, Jen-Pei
|
| ISBN |
9781420011678 |
|
1420011677 |
|
